ELV Stock Analysis: Buy, Sell, or Hold?
ELV - Elevance Health, Inc.
$375.84
-0.56 (-0.15%)
▼
5d:
-0.49%
30d:
-9.7%
90d:
-0.15%
HOLD
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Oct 21, 2026
Smart Money Accumulation
None View Scanner →
Strength: 6.8/10
Get Alerted When ELV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ELV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: ELV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$504.28
Based on 6.6% avg growth
INTRINSIC VALUE TODAY
$313.12
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 12.4x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ELV is currently trading at $375.84, which is considered slightly low relative to its 30-day fair value range of $379.92 to $413.85. The stock's valuation (Forward PE: 12.7) is in line with its historical norms (12.4). At these levels, the market is pricing in 0.9% annual earnings growth.
Technical Outlook: Technically, ELV is in a strong uptrend. Immediate support is located at $362.98, while resistance sits at $396.00.
Market Sentiment: ELV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $449.10 (+19.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ELV is in a strong uptrend. Immediate support is located at $362.98, while resistance sits at $396.00.
Market Sentiment: ELV has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $449.10 (+19.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$379.92 -
$413.85
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.1%
Protect Your Profits
Holding ELV? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($449.10)
- BULLISH: Expecting earnings turnaround to 0.9% growth with 1.4% revenue growth
Trading Range Analysis
30-Day Trading Range
$379.92 -
$413.85
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$362.98
Resistance Level
$396.00
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.68
Wall Street Target
$449.10
(+19.5%)
Revenue Growth (YoY)
1.4%
Earnings Growth (YoY)
-13.1%
Profit Margin
2.5%
Valuation Premium vs History
+0.9% premium
PE vs Historical
12.7 vs 12.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+0.9%
(market-implied from PE analysis)
1-Year Target
$379.22
(+1%)
2-Year Target
$382.64
(+2%)
3-Year Target
$386.08
(+3%)
3-Yr Target (if PE normalizes)
(PE: 13→12)
PE COMPRESSION
$377.48
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 9.1%)
$798.10
(+112%)
Base:
(SPY PE: 12.7, Growth: 9.1%)
$488.28
(+30%)
Bear:
(PE: 10.8, Growth: 9.1%)
$415.04
(+10%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (17x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 16.64 | Current EPS (TTM): $22.62
Bull Case
$542.43
(+44%)
Analyst growth 31.0%, PE expands to 18.3
Base Case
$493.12
(+31%)
Market implied 31.0%, PE stable at 16.6
Bear Case
$255.95
(-32%)
Severe decline -20.0%, PE contracts to 14.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: August 02, 2026 5:50 PM ET
Data refreshes hourly during market hours. Next update: 6:50 PM
Data refreshes hourly during market hours. Next update: 6:50 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELV showing a specific setup today?
Insider Activity (6 Months)
2
Buys
2
Sells
0
Net
INSIDERS SELLING
Recent Transactions
Ro Khanna
SELL
2026-03-30
Amy W Schulman
SELL
26 shares
2026-03-12
Ro Khanna
BUY
2026-02-24
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$114 | 51 HOLD |
|
UNH
UnitedHealth Group Incor… |
STRONG BUY
27 analysts |
$475 | 50 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$343 | 47 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$408 | 54 HOLD |
|
CNC
Centene Corp |
BUY
19 analysts |
$71 | 43 HOLD |
Advanced ELV Option Strategies
Professional options setups generated by AI based on today's ELV price and gamma walls.
